Did management answer the analysts?
12 analyst questions audited, 1 evaded or deflected.
View Claim Ledger →Camlin Fine Sciences reported Q3 FY26 revenue of ₹572 crore, up 6% YoY, driven by blends growth (+11% YoY) and the VPI acquisition.
✓ Verified against BSE filing
Camlin Fine Sciences reported Q3 FY26 revenue of ₹572 crore, up 6% YoY, driven by blends growth (+11% YoY) and the VPI acquisition. EBITDA margin contracted 60 bps YoY to 6.7%, impacted by lower vanillin sales (deliberately deferred to benefit from US tariff reduction) and margin pressure in the straights business (TBHQ/BHA). Management guided for FY27 vanillin volumes of 4,000 metric tons (vs ~2,400 in FY26) and blends growth of 20-25%, targeting overall revenue of ₹2,200 crore. A fire at a Brazil blending unit destroyed ~₹33 crore of inventory and equipment, but insurance coverage is expected. Key risk: delay in US tariff reduction or liquidation of European subsidiary could impact cash flows.
12 analyst questions audited, 1 evaded or deflected.
View Claim Ledger →Delay in US tariff reduction
View Risks →Full transcript text is available on this route.
Read Transcript →Management expects to double vanillin sales from ~2,400 MT in FY26 to 4,000 MT in FY27.
Blends segment grew 11% YoY, driven by organic growth and VPI acquisition (₹13 crore contribution).
Company holds 400 MT of vanillin inventory in US, partly committed at $12.5/kg, awaiting tariff benefit.
Fire destroyed inventory (₹28 crore) and equipment (₹4.5 crore) at a blending unit; insurance survey pending.
Management expects to sell 4,000 metric tons of vanillin in FY27, up from ~2,400 MT in FY26, driven by US tariff reduction and channel stock liquid...
If the US-India trade deal is not signed, vanillin realizations may remain at $12.5/kg instead of improving to $14-15/kg, impacting margins.
View Risks →